Aristo Pharmaceuticals Pvt Ltd
Letrozole (2.5mg)
Letpro 2.5mg Tablet is used to treat breast cancer in post-menopausal women, either alone or with other treatments, and to stop the tumor from spreading to other parts of the body.
Tablet
Letpro 2.5mg Tablet is an aromatase inhibitor that helps treat breast cancer in post-menopausal women. It may be used alone or with other treatments, such as surgery or radiation. It can also be used in patients with advanced breast cancer to stop the tumor from spreading to other parts of the body. It works by decreasing the amount of estrogen produced in the body, which can slow down or stop the growth of some breast cancers that need estrogen to grow.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Letpro 2.5mg Tablet may be taken with or without food but it is better to take it at a fixed time.
No common side effects listed.
Consuming alcohol with Letpro 2.5mg Tablet does not cause any harmful side effects.
Letpro 2.5mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Letpro 2.5mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
Estradiol Ethinyl Estradiol Tibolone Estriol
Letpro 2.5mg Tablet is an aromatase inhibitor. It works by decreasing the amount of estrogen (natural female hormone) produced in the body. This decrease in estrogen can slow down or stop the growth of some breast cancers that need estrogen to grow.
You have been prescribed Letpro 2.5mg Tablet for the treatment of breast cancer. It can be taken with or without food. Do not drive or do anything requiring concentration until you know how Letpro 2.5mg Tablet affects you. It may cause increased sweating and hot flushes. Try to keep cool by wearing light and airy clothes. Your doctor may monitor your cholesterol level and bone mineral density (BMD) regularly as Letpro 2.5mg Tablet can alter their levels.
Letpro 2.5mg Tablet is an aromatase inhibitor used to treat breast cancer in women who are no longer menstruating, either due to menopause or after surgery or chemotherapy.
Letpro 2.5mg Tablet is also known as an anti-estrogen drug. It acts by reducing the production of estrogen in your body through blocking the aromatase enzyme, which produces estrogen. Estrogen stimulates certain types of breast cancer growth. By reducing estrogen, Letpro 2.5mg Tablet may prevent these cancers from growing and spreading.
The duration of Letpro 2.5mg Tablet treatment is determined by the stage and spread of your breast tumor. If it's in an advanced state or has metastasized, you may need to continue taking it until there's clinical evidence of disease progression. In cases where it's prescribed after tamoxifen or surgery, it usually lasts for 5 years, or until the tumor returns, whichever comes first. Sometimes, Letpro 2.5mg Tablet can be used in a sequential treatment schedule: 2 years of Letpro 2.5mg Tablet followed by 3 years of Tamoxifen.
Yes, you can safely combine irbesartan and Letpro 2.5mg Tablet as they are usually used together.
While rare, it may increase the risk of developing cataracts. If you experience blurred vision or eye irritation, seek immediate medical attention from your doctor.
Sweating can be related to hot flushes, which are common side effects of Letpro 2.5mg Tablet. This happens due to decreased estrogen levels in your body. As your body adjusts to the medication, the frequency of hot flushes will decrease. However, some individuals may continue experiencing them and then subside a few months after treatment finishes. Consult with your doctor if the side effects are particularly bothersome.
Serious side effects from Letpro 2.5mg Tablet are uncommon and occur in very few people. These include stroke, angina, heart attack, blood clotting, cataract formation, osteoporosis, and severe skin reactions.
Letpro 2.5mg Tablet may lead to bone thinning or wasting (osteoporosis) due to the decline in estrogen levels in your body. Your doctor might conduct bone density measurements at different stages of treatment - before, during, and after treatment.
Letpro 2.5mg Tablet is currently restricted from use in the induction of ovulation in anovulatory infertility, as per the Ministry of Health and Family Welfare.